Problems in interpreting RA family studies Rheumatoid arthritis family studies fall into two categories. The first are those studies that deliberately seek out multicase families. The main purpose of these studies is to determine whether genetic markers cosegregate with the presence of the disease, thus suggesting genetic linkage. The second are studies which attempt to establish the extent of the familial nature by avoiding any bias towards multicase families, so that, for example, disease concordance rates might be estimated in the families of all patients attending a rheumatology clinic, or in a defined community. Both types of study are essential to the understanding of the familial nature of RA.
Some ground rules for interpreting any RA family study must Secondly, how does the study define RA? Up to 1%9 familial aggregation studies were based on the unsteady foundation of 'clinical' diagnostic criteria-that is, one researcher's opinion based on textbook descriptions ofthe disease. 5 Little wonder therefore that these studies produced a range of RA prevalence ratios (comparing disease in first degree relatives with that in controls) of 0 9 to 15-2. 8 The discrepancy between the concordance rates in these studies is not as great as it initially seems, as there are obvious differences between them. Firstly, the difference in ascertainment method, in that community based RA seems to be less fmilial than hospital ascertained RA.2' Secondly, record linkage to establish diagnosis in the Finnish study was less reliable than patient investigation and examination. Most importantly, however, the figure of 300o from the ARC twin study only included seropositive erosive disease, whereas the population survey included seropositive and seronegative probands in the 12-3%. If the seronegative twins in the ARC study are included the concordance rate drops to 15'8%, a figure much more comparable with the population data. Therefore monozygotic concordance rates for RA are not high. By comparison, the figure for insulin dependent diabetes mellitus (IDDM) is 36%. 22 Given that monozygotic twins are more likely to share their environment and that this may artificially raise concordance rates, it seems that the genetic contribution to RA is low.
In agreement with this, the most valid studies on familial aggregation only show a small increase in risk to first degree relatives. '5 23-25 The most recent population study estimates a typical prevalence ratio of 17 (95% confidence limits 10 to 2-9) for first degree relatives compared with controls.2 In other words, if RA affects 1'5% of a population, and 100 patients with RA were ascertained from this population, only two or three patients would be expected to have first degree relatives with RA (though this figure may be higher in hospital based studies26).
It also suggests that when two members of a family develop RA this may be because the disease is common. This argument is unacceptable, however, in those rare families in which healthy subjects are the exception and not the rule.
What are the inherited susceptibility factors in RA? Tounderstand why RA clusters in some families a review ofthe recent advances in immunogenetics is necessary. More is understood of the immunogenetics of IDDM than those of RA. This is probably because IDDM is more familial than RA, the disease starts earlier in life,2" and it is more likely to come to hospital attention because the consequences of non-treatment are life threatening. As both diseases are thought to be T cell dependent autoimmune diseases,28 29 and they may occur together in the same families,30 it is informative to consider why IDDM might cluster in some families, draw analogies with the RA data, and consider some of the unanswered questions.
There are strong associations between HLA-DR3, DR4 and IDDM, so that 95% of patients are DR3 or DR4 positive, or both.3' DR2 is negatively associated.32 HLA haplotype sharing of two, one, and no haplotypes would be expected to be 25%, 50%, and 25% respectively in dually affected sib pairs if there was no linkage between HLA and IDDM susceptibility genes. The observed distribution is significantly different at 53-6%, 39-1%, and 7-3% respectively,27 suggesting that IDDM susceptibility genes are either very close to, or actually in, the HLA region. The sibling recurrence risk of IDDM is about 6%, but siblings HLA-identical with the proband have a calculated and observed risk of 12-90/o, hemi-identical sibs 4-7%, and non-identical sibs 1-8%. 27 The greatest risk of 19-2% is in sibs sharing two haplotypes with a DR3/4 proband.27 Parental origin of the HLA haplotype is important in that there is a six times greater risk to children of an affected father than mother, even more marked with an inherited DR4 haplotype.3' The modes of inheritance are thought to be dominant-like in DR4 haplotypes in the absence of DR3, recessive-like in DR3 haplotypes in the absence of DR4, and a synergistic effect is thought to occur in the presence of both. 27 The major histocompatibility complex (MHC) linked factor is more complex than a one locus, multiple allele model, however. Non-DR HLA genes are also important-most notably, the presence of aspartate at position 57 of the first hypervariable region of the DQ , chain protects from development of the disease. 28 There is evidence that it is the DQ subregion that is the main determinant of disease susceptibility, and that the positive associations between DR alleles and IDDM are due to linkage disequilibrium between DR When these gaps are filled we will be in a better position to identify those families that are particularly prone to RA, to understand why they develop it, and, armed with that knowledge, hopefully have a better chance in preventing it.
